WVE-006
WVE-006-002
Phase 2 small_molecule active
Quick answer
WVE-006 for Alpha-1 antitrypsin deficiency (AATD) is a Phase 2 program (small_molecule) at Elan Pharma International with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Elan Pharma International
- Indication
- Alpha-1 antitrypsin deficiency (AATD)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active